RenovaCare, Inc. (RCAR)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 2, 2026
0.00%
Market Cap 87.00
Revenue (ttm) n/a
Net Income (ttm) -5.74M
Shares Out 87.35M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 2,535
Open 0.0000
Previous Close n/a
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0010
Beta -104.68
RSI 46.95
Earnings Date n/a

About RenovaCare

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regener... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1983
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol RCAR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.